Koichi Fukunaga
Overview
Explore the profile of Koichi Fukunaga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
270
Citations
2885
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sasaki H, Miyata J, Kawana A, Fukunaga K
Front Allergy
. 2025 Mar;
6:1548338.
PMID: 40083723
Eosinophils are immune cells that are crucial for the pathogenesis of allergic diseases, such as asthma. These cells play multifunctional roles in various situations, including infection. They are activated during...
2.
Sonehara K, Uwamino Y, Saiki R, Takeshita M, Namba S, Uno S, et al.
Cell Genom
. 2025 Mar;
5(3):100783.
PMID: 40043710
Vaccine immunogenicity is influenced by the vaccinee's genetic background. Here, we perform a genome-wide association study of vaccine-induced SARS-CoV-2-specific immunoglobulin G (IgG) antibody titers and T cell immune responses in...
3.
Yata T, Sato G, Ogawa K, Naito T, Sonehara K, Saiki R, et al.
Cell Genom
. 2025 Feb;
5(3):100776.
PMID: 39986280
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease characterized by optic neuritis and transverse myelitis, with an unclear genetic background. A genome-wide meta-analysis of NMOSD in Japanese individuals...
4.
Tagaya E, Shinada J, Nagase H, Terada-Hirashima J, Hojo M, Sugihara N, et al.
J Asthma
. 2025 Jan;
:1-11.
PMID: 39874464
Background: Persistent cough bothers many patients with asthma because it worsens their quality of life; therefore, it must be remedied immediately. The efficacy of triple therapy as a first-line treatment...
5.
Shimada T, Maetani T, Chubachi S, Tanabe N, Asakura T, Namkoong H, et al.
J Cachexia Sarcopenia Muscle
. 2025 Jan;
16(1):e13721.
PMID: 39868664
Background: Chest computed tomography (CT) is a valuable tool for diagnosing and predicting the severity of coronavirus disease 2019 (COVID-19) and assessing extrapulmonary organs. Reduced muscle mass and visceral fat...
6.
Nagase H, Kobayashi K, Toma-Hirano M, Suzukawa M, Harada N, Masaki K, et al.
Allergol Int
. 2025 Jan;
PMID: 39848869
Background: Although randomized controlled trials (RCT) have demonstrated the efficacy of mepolizumab for asthma, they have excluded certain patient subgroups. To bridge the gap between RCT and real-world practice, the...
7.
Watase M, Shiraishi Y, Chubachi S, Tanabe N, Maetani T, Asakura T, et al.
Circ J
. 2025 Jan;
89(3):373-381.
PMID: 39828330
Background: Coronary artery calcification (CAC) detected through chest computed tomography (CT) strongly predicts cardiovascular events in asymptomatic individuals undergoing primary prevention. Few studies with limited sample sizes have investigated the...
8.
Shirai T, Hirai K, Akamatsu T, Mizumura K, Sasano H, Harada N, et al.
Allergol Int
. 2025 Jan;
PMID: 39809630
No abstract available.
9.
Okada M, Ohgino K, Horiuchi K, Sayama K, Arai D, Watase M, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768737
Atezolizumab, an immune checkpoint inhibitor (ICI), was used in a phase III clinical trial, i.e., the OAK trial, of previously treated patients with non-small cell lung cancer. We aimed to...
10.
Sasa N, Kojima S, Koide R, Hasegawa T, Namkoong H, Hirota T, et al.
Nat Genet
. 2025 Jan;
57(1):65-79.
PMID: 39753770
Aberrant immune responses to viral pathogens contribute to pathogenesis, but our understanding of pathological immune responses caused by viruses within the human virome, especially at a population scale, remains limited....